Prothrombin complex concentrate (Octaplex): A Portuguese experience in 1152 patients

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 3, 2012, Pages 222-228

  Carvalho, Manuela C ^a   Rodrigues, Anabela G ^b   Conceição, Luísa M ^c   Galvão, Miguel L ^b   Ribeiro, Luis C ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c Octapharma   (Portugal)

Author keywords

efficacy; Octaplex; prothrombin complex concentrates

Indexed keywords

PROTHROMBIN COMPLEX;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; CHILD; CLINICAL ASSESSMENT; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INTERNATIONAL NORMALIZED RATIO; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPEN STUDY; PORTUGAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMORRHAGE; HEMOSTATICS; HUMANS; INFANT; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASES; MALE; MIDDLE AGED; OBSERVATION; PORTUGAL; RETROSPECTIVE STUDIES;

EID: 84859334265     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328351250f     Document Type: Article

References (22)

1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:160S-198S. (Pubitemid 351892967)
2. Makris M, Watson HG. The management of coumarin-induced overanticoagulation annotation. Br J Haematol 2001; 114:271-280.
3. Samama CM. Prothrombin complex concentrates: a brief review. Eur J Anaesthesiol 2008; 25:784-789.
4. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003; 107:1692-1711. (Pubitemid 36397341)
5. Sorensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R. Clinical review: prothrombin complex concentrates: evaluation of safety and thrombogenicity. Crit Care 2011; 15:201.
6. Scharf RE. Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention. Hamostaseologie 2009; 29:388-398.
7. Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus 2010; 8:149-154.
8. Hellstern P, Halbmayer WM, Kohler M, Seitz R, Muller-Berghaus G. Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary. Thromb Res 1999; 95:S3-S6. (Pubitemid 29461041)
9. Franken T, Rees W, Hubner N, Albers J, Gansera B, Uhl M, et al. Octaplex in routine clinical use for prophylaxis and therapy of bleeding in patients with prothrombin complex factor deficiency. Crit Care 2007; 11:376.
10. Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition: 2005 update. Br J Haematol 2006; 132:277-285. (Pubitemid 43381534)
11. Hanley JP. Warfarin reversal. J Clin Pathol 2004; 57:1132-1139. (Pubitemid 39486516)
12. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14:R52.
13. Octapharma. Octaplex1 summary of product of characteristics. 2008 [cited 2010 26 August]; Available from: http://www.medicines.org.uk/ emc/medicine/21897/SPC/octaplex%C2%AE/.
14. Makris M. Optimisation of the prothrombin complex concentrate dose for warfarin reversal. Thromb Res 2005; 115:451-453. (Pubitemid 40409976)
15. Riess HB, Meier-Hellmann A, Motsch J, Elias M, Kursten FW, Dempfle CE. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res 2007; 121: 9-16. (Pubitemid 350025993)
16. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992; 23:972-977.
17. Lorenz R, Kienast J, Otto U, Kiehl M, Schreiter D, Haertel S, et al. Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study. Blood Coagul Fibrinolysis 2007; 18:565-570. (Pubitemid 47344305)
18. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77:477-480. (Pubitemid 27121012)
19. Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 2008; 6:622-631. (Pubitemid 351404929)
20. Lorenz R, Kienast J, Otto U, Egger K, Kiehl M, Schreiter D, et al. Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol 2003; 15:15-20. (Pubitemid 36135657)
21. Schick KS, Fertmann JM, Jauch KW, Hoffmann JN. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009; 13:R191.
22. Demeyere R, Gillardin S, Arnout J, Strengers PF. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study. Vox sanguinis 2010; 99:251-260.